0001104659-26-095672.txt : 20260813
0001104659-26-095672.hdr.sgml : 20260813
20260813114645
ACCESSION NUMBER: 0001104659-26-095672
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20260813
DATE AS OF CHANGE: 20260813
EFFECTIVENESS DATE: 20260813
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: 801 West Biotech Opportunity Series 1
CENTRAL INDEX KEY: 0002081340
ORGANIZATION NAME:
EIN: 392938978
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-594118
FILM NUMBER: 261271360
BUSINESS ADDRESS:
STREET 1: 310 N STATE STREET
STREET 2: SUITE 220
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97034
BUSINESS PHONE: (503) 548-1730
MAIL ADDRESS:
STREET 1: 310 N STATE STREET
STREET 2: SUITE 220
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97034
D
1
primary_doc.xml
X0708
D
LIVE
0002081340
801 West Biotech Opportunity Series 1
310 N STATE STREET
SUITE 220
LAKE OSWEGO
OR
OREGON
97034
503-548-1730
DELAWARE
None
None
Other
Series of a Delaware series limited partnership
true
2025
N/A
801 West Capital Management, LLC
310 N State Street
Suite 220
Lake Oswego
OR
OREGON
97034
Executive Officer
General Partner of the Issuer
Jonathan
McGowan
310 N State Street
Suite 220
Lake Oswego
OR
OREGON
97034
Executive Officer
Executive officer of 801 West Capital Management, LLC, General Partner of the Issuer
Scott
Kelly
310 N State Street
Suite 220
Lake Oswego
OR
OREGON
97034
Executive Officer
Executive officer of 801 West Capital Management, LLC, General Partner of the Issuer
Corey
Von Allmen
310 N State Street
Suite 220
Lake Oswego
OR
OREGON
97034
Executive Officer
Executive officer of 801 West Capital Management, LLC, General Partner of the Issuer
Pooled Investment Fund
Hedge Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
2025-08-01
true
true
false
0
Indefinite
56885000
Indefinite
false
27
0
0
0
true
false
801 West Biotech Opportunity Series 1
/s/ Jonathan McGowan
Jonathan McGowan
Managing Partner of the GP to the Issuer
2026-08-13